Literature DB >> 18438939

Preconditioning with cobalt chloride or desferrioxamine protects oligodendrocyte cell line (MO3.13) from tumor necrosis factor-alpha-mediated cell death.

Song-yi Yao1, Mohammed Soutto, Subramaniam Sriram.   

Abstract

Hypoxia-inducible factor-1alpha (HIF-1alpha) is a transcription factor induced under hypoxic conditions. HIF-1alpha promotes the expression of genes encoding proteins that increase the cellular supply of oxygen and promote survival in periods of cellular stress and availability of cellular energy. We examined the effect of desferrioxamine (DFO) and cobalt chloride (CoCl(2)), two agents known to increase the stability of HIF-1alpha, and its effect on the survivability of an oligodendroglial cell line, MO3.13, when cultured with tumor necrosis factor-alpha (TNFalpha). Our studies showed that, unlike a murine microglial cell line (BV-2), MO3.13 cells do not induce HIF-1alpha in the presence of TNFalpha. MO3.13 cells do stabilize HIF-1alpha in the presence of DFO or CoCl(2). When MO3.13 cell were preconditioned with either DFO or CoCl(2), addition of TNFalpha further increased protein levels of HIF-1alpha. The mechanisms that underlie the increase in protein levels of HIF -1alpha seen, following addition of TNFalpha in preconditioned cells is due to an increase in transcription of the HIF-1alpha gene. Increased cellular levels of HIF-1alpha is associated with improved survival of MO3.13 cells, when cultured with TNFalpha after a period of preconditioning by DFO or CoCl(2). These studies suggest that compoundsthat increase HIF-1alpha can function as neuroprotective agents in inflammatory disorders of the CNS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438939     DOI: 10.1002/jnr.21697

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia.

Authors:  Espen J Walker; Gary A Rosenberg
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

2.  Hypoxic conditions differentially regulate TAZ and YAP in cancer cells.

Authors:  Libo Yan; Qingchun Cai; Yan Xu
Journal:  Arch Biochem Biophys       Date:  2014-07-29       Impact factor: 4.013

Review 3.  Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases.

Authors:  S M Touhidul Islam; Jeseong Won; Mushfiquddin Khan; Mark D Mannie; Inderjit Singh
Journal:  Immunology       Date:  2021-04-27       Impact factor: 7.215

Review 4.  Iron chelation and multiple sclerosis.

Authors:  Kelsey J Weigel; Sharon G Lynch; Steven M LeVine
Journal:  ASN Neuro       Date:  2014-01-30       Impact factor: 4.146

5.  Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.

Authors:  Carmen Navarrete; Francisco Carrillo-Salinas; Belén Palomares; Miriam Mecha; Carla Jiménez-Jiménez; Leyre Mestre; Ana Feliú; Maria L Bellido; Bernd L Fiebich; Giovanni Appendino; Marco A Calzado; Carmen Guaza; Eduardo Muñoz
Journal:  J Neuroinflammation       Date:  2018-03-01       Impact factor: 8.322

Review 6.  Cannabidiol and Other Cannabinoids in Demyelinating Diseases.

Authors:  Carmen Navarrete; Adela García-Martín; Alain Rolland; Jim DeMesa; Eduardo Muñoz
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.